
When we declare a patient "cancer-free," there is always a quiet pause in every oncologist's heart. We celebrate the remission, but we also know that breast cancer, in some women, has a tendency to whisper back years later. Recognising those whispers early can make all the difference. Understanding Recurrence: A Practical ViewBreast cancer recurrence can be local (in or near the breast or chest wall), regional (in nearby lymph nodes), or distant/metastatic (when it travels to organs such as the bones, lungs, liver, or brain). Globally, recurrence occurs in about 20 to 30 percent of women within the first five to ten years after initial treatment. In India, relapse rates tend to be slightly higher in real-world settings, largely because many women begin treatment at a more advanced stage. What I Tell My Patients to Watch ForOver a decade of oncology practice, I have come to understand that recurrence rarely announces itself dramatically. It often begins subtly - sometimes as a feeling, not a finding. Local or Regional Signs
Systemic or Distant Clues
Sometimes, the signs are less specific - prolonged fatigue, unexpected weight loss, or just a sense of not feeling yourself. I often tell my patients: your body remembers what normal feels like. Listen to it. Why Indian Women Face a Higher Relapse BurdenAccording to the ICMR-NCDIR report (2023), 59 percent of Indian women are diagnosed only after the breast cancer has spread to lymph nodes, and 11 percent are diagnosed when it has already become metastatic. Late diagnosis inevitably increases the risk of recurrence. Unlike in the West, screening coverage in India remains low. Mammography uptake among women above 45 is still below five percent. Many survivors struggle to maintain long-term follow-up due to cost, stigma, or simply being lost to care once treatment ends. As oncologists, we see this pattern repeatedly. The first five years are crucial, but vigilance must extend well beyond a decade. The New Frontier: Detecting Relapse Before It SpeaksGlobally, there is exciting progress in the field of liquid biopsy - a blood test that can detect circulating tumour DNA. In a recent UK-India collaborative study, these tests were able to predict recurrence up to 15 months before conventional imaging could. While not yet widely available, this technology represents a major step forward in proactive survivorship care. At MOC, we believe it will eventually redefine follow-up protocols for breast cancer patients. Patterns from the ClinicCertain tumour profiles tend to relapse earlier. These include triple-negative and HER2-positive cancers, as well as those diagnosed in younger women under the age of 40. I often remind patients that recurrence does not necessarily mean treatment failure. It reflects the underlying biology of the disease. Many relapses today are manageable as chronic conditions through targeted therapies and hormone blockade. What matters most is early detection. Practical Guidance for Survivors
The Emotional LandscapeThe fear of recurrence is real and often under-acknowledged. Many breast cancer survivors hesitate to report symptoms because they dread hearing the word "cancer" again. Yet paradoxically, denial can delay the chance for a cure. In my practice, some of the most successful second remissions have happened because a patient insisted on checking "a tiny lump that didn't feel right." That intuition saved their life. (By Dr Kasturi Baruah, Oncologist, M|O|C Cancer Care Panvel) Disclaimer: The opinions expressed within this article are the personal opinions of the author. NDTV is not responsible for the accuracy, completeness, suitability, or validity of any information in this article. All information is provided on an as-is basis. The information, facts, or opinions appearing in the article do not reflect the views of NDTV and NDTV does not assume any responsibility or liability for the same. |
Track Latest News Live on NDTV.com and get news updates from India and around the world